AAFP policy addresses issues related to prior authorizations

AAFP policy addresses issues related to prior authorizations

(HealthDay)—A new policy addresses some of the problematic issues associated with prior authorizations, according to a report published by the American Academy of Family Physicians (AAFP).

In April, the AAFP Board of Directors voted to adopt an official AAFP policy on prior authorizations, which describes the importance of addressing this issue for family physicians.

The policy notes that prior authorizations create significant barriers for the delivery of timely and evidence-based care to patients. In order to deal with this process, prior authorizations should be standardized and universally electronic throughout the industry. In most circumstances, physicians should have the freedom to prescribe and order what their patients need, without prior authorizations, using appropriate clinical knowledge, training, and experience. An evidence-based, transparent, and efficient system is necessary to ensure timely access and optimal patient outcomes for those instances where prior authorizations are clinically relevant. Prior authorizations should not be required for who contract with health plans, or when physicians prescribe generic medications for their patients. Step therapy protocols can be particularly problematic and should not be mandatory for already on a course of treatment.

According to the report, "the Academy's recent action on prior authorizations came on the heels of a call by the AAFP and a coalition of 16 other organizations earlier this year to reform prior authorization and utilization management requirements."


Explore further

Steps given to minimize burden of prior authorizations

More information: More Information

Copyright © 2017 HealthDay. All rights reserved.

Citation: AAFP policy addresses issues related to prior authorizations (2017, June 5) retrieved 5 April 2020 from https://medicalxpress.com/news/2017-06-aafp-policy-issues-prior-authorizations.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments